NCT01489813 2025-02-05Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer TreatmentEmory UniversityPhase 2 Completed36 enrolled 7 charts
NCT00118040 2021-06-10Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder CancerNational Cancer Institute (NCI)Phase 2 Completed60 enrolled 24 charts